Vaccine experts — including those who serve on advisory committees for the US Food and Drug Administration and the US Centers for Disease Control and Prevention — have questions about data released Monday by AstraZeneca about its Covid-19 vaccine.
AstraZeneca Covid vaccine: Experts have questions about the Phase 3 trial data
More Stories
Despite promises of solidarity on Covid-19, rich countries are snapping up the supply of promising vaccines
Historic U.S. COVID vaccine campaign launches with convoy of trucks
Brazil rolls out COVID-19 vaccination plan